Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working Group.
作者信息
Schaefer Robin, Donaldson Logan, Leus Mitchell, Osakwe Chukwunomso E, Chimukangara Benjamin, Dalal Shona, Duerr Ann, Gao Fei, Glidden David V, Grinsztejn Beatriz, Justman Jessica, Kumwenda Grace, Laeyendecker Oliver, Lee Ha Youn, Maldarelli Frank, Mayer Kenneth H, Murray Jeffrey, Parekh Bharat S, Rice Brian, Robertson Michael N, Saito Suzue, Vannappagari Vani, Warren Mitchell, Zeballos Diana, Zinserling Jörg, Miller Veronica
机构信息
Forum for Collaborative Research, University of California, Berkeley, Washington, District of Columbia, United States of America.
National Institutes of Health, Bethesda, Maryland, United States of America.
出版信息
PLOS Glob Public Health. 2024 Oct 24;4(10):e0003878. doi: 10.1371/journal.pgph.0003878. eCollection 2024.
Abstract
摘要
相似文献
1
Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working Group.艾滋病病毒预防试验的喜人成果凸显了全球卫生领域合作的益处：艾滋病病毒近期感染检测论坛工作组的观点
PLOS Glob Public Health. 2024 Oct 24;4(10):e0003878. doi: 10.1371/journal.pgph.0003878. eCollection 2024.
2
Short Communication: Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda.短篇通讯：验证 Asante HIV-1 快速近期检测法在乌干达检测近期 HIV-1 感染的有效性。
AIDS Res Hum Retroviruses. 2021 Dec;37(12):893-896. doi: 10.1089/AID.2020.0279. Epub 2021 Feb 25.
3
Evaluation of the accuracy of the Asanté assay as a point-of-care rapid test for HIV-1 recent infections using serum bank specimens from blood donors in South Africa, July 2018 - August 2021.评估 Asanté 检测法作为一种即时检测点用于艾滋病毒 1 型近期感染的准确性，使用 2018 年 7 月至 2021 年 8 月南非献血者血清库标本。
S Afr Med J. 2023 Oct 23;113(10):42-48. doi: 10.7196/SAMJ.2023.v113i10.678.
4
Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana.博茨瓦纳与HIV-1C感染近期情况相关的病毒多样性分析。
PLoS One. 2016 Aug 23;11(8):e0160649. doi: 10.1371/journal.pone.0160649. eCollection 2016.
5
Experiences and lessons learned from the real-world implementation of an HIV recent infection testing algorithm in three routine service-delivery settings in Kenya and Zimbabwe.在肯尼亚和津巴布韦的三个常规服务提供环境中实施 HIV 近期感染检测算法的真实世界经验和教训。
BMC Health Serv Res. 2021 Jun 22;21(1):596. doi: 10.1186/s12913-021-06619-6.
6
Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.使用 HIV 近期感染检测方法进行 HIV 发病率估计和其他监测应用案例：系统评价。
JMIR Public Health Surveill. 2022 Mar 11;8(3):e34410. doi: 10.2196/34410.
7
The Recency Period for Estimation of Human Immunodeficiency Virus Incidence by the AxSYM Avidity Assay and BED-Capture Enzyme Immunoassay in the Republic of Korea.韩国采用AxSYM亲和力检测法和BED捕获酶免疫分析法估算人类免疫缺陷病毒发病率的近期时间段。
Osong Public Health Res Perspect. 2014 Aug;5(4):187-92. doi: 10.1016/j.phrp.2014.06.002. Epub 2014 Jun 28.
8
Global and local networking for HIV/AIDS prevention: the case of the Saathii E-forum.全球及地方层面的艾滋病预防网络：以萨蒂电子论坛为例。
J Health Commun. 2008 Jun;13(4):326-44. doi: 10.1080/10810730802063363.
9
Perceived benefits, challenges, and recommendations for HIV research dissemination and implementation science efforts in Tanzania: Findings from the HIV/AIDS Research Forum brainstorming session.坦桑尼亚艾滋病毒研究传播与实施科学工作的感知益处、挑战及建议：艾滋病毒/艾滋病研究论坛头脑风暴会议的结果
PLOS Glob Public Health. 2022 Oct 26;2(10):e0000952. doi: 10.1371/journal.pgph.0000952. eCollection 2022.
10
The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards.HIV 基因序列测定符合近期感染率和平均持续时间的假阴性率性能标准。
Sci Rep. 2017 Aug 7;7(1):7480. doi: 10.1038/s41598-017-07490-4.
本文引用的文献
1
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.双年度利纳卡帕韦或每日 F/TAF 用于预防 cisgender 女性中的 HIV。
N Engl J Med. 2024 Oct 3;391(13):1179-1192. doi: 10.1056/NEJMoa2407001. Epub 2024 Jul 24.
2
Is HIV epidemic control by 2030 realistic?到 2030 年实现艾滋病病毒的流行控制是否现实？
Lancet HIV. 2024 Jul;11(7):e489-e494. doi: 10.1016/S2352-3018(24)00098-5.
3
Precision detection of recent HIV infections using high-throughput genomic incidence assay.使用高通量基因组发病率检测法对近期HIV感染进行精准检测。
Microbiol Spectr. 2023 Sep 15;11(5):e0228523. doi: 10.1128/spectrum.02285-23.
4
Facilitating Next-Generation Pre-Exposure Prophylaxis Clinical Trials Using HIV Recent Infection Assays: A Consensus Statement from the Forum HIV Prevention Trial Design Project.利用 HIV 近期感染检测促进下一代暴露前预防临床试验：来自论坛 HIV 预防试验设计项目的共识声明。
Clin Pharmacol Ther. 2023 Jul;114(1):29-40. doi: 10.1002/cpt.2830. Epub 2023 Jan 5.
5
A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications.一项关于限制抗原亲和力酶免疫测定法检测近期HIV-1感染以扩大支持应用的系统评价。
J Virus Erad. 2022 Sep 7;8(3):100085. doi: 10.1016/j.jve.2022.100085. eCollection 2022 Sep.
6
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.卡博特韦用于女性艾滋病毒 1 型的预防：来自 HPTN 084 的结果，一项 3 期、随机临床试验。
Lancet. 2022 May 7;399(10337):1779-1789. doi: 10.1016/S0140-6736(22)00538-4. Epub 2022 Apr 1.
7
HIV prevention: better choice for better coverage.艾滋病毒预防：更好的选择，更好的覆盖率。
J Int AIDS Soc. 2022 Jan;25(1):e25872. doi: 10.1002/jia2.25872.
8
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.卡博特韦用于预防顺性别男性和跨性别女性中的 HIV。
N Engl J Med. 2021 Aug 12;385(7):595-608. doi: 10.1056/NEJMoa2101016.
9
Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.采纳和使用口腔暴露前预防指南：全球概述和预测研究。
Lancet HIV. 2021 Aug;8(8):e502-e510. doi: 10.1016/S2352-3018(21)00127-2. Epub 2021 Jul 12.
10
Why ethics guidance needs to be updated for contemporary HIV prevention research.为何当代HIV预防研究需要更新伦理指导。
J Int AIDS Soc. 2020 May;23(5):e25500. doi: 10.1002/jia2.25500.
Zotero 插件